Clinical Colorectal Cancer

1

Adjuvant Systemic Chemotherapy After Putative Curative Resection of Colorectal Liver and Lung Metastases

Brandi, Giovanni, Derenzini, Enrico, Falcone, Alfredo, Masi, Gianluca, Loupakis, Fotios, Pietrabissa, Andrea, Pinna, Antonio D., Ercolani, Giorgio, Pantaleo, Maria A., Di Girolamo, Stefania, Grazi, Gi

Journal:

Year:

2013

Language:

english

File:

PDF, 278 KB

english, 2013

2

Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer

Bendell, Johanna C., Ervin, Thomas J., Gallinson, David, Singh, Jaswinder, Wallace, James A., Saleh, Mansoor N., Vallone, Marcy, Phan, See-Chun, Hack, Stephen P.

Journal:

Clinical Colorectal Cancer

Year:

2013

Language:

english

File:

PDF, 608 KB

english, 2013

3

Clinical Utility of KRAS and BRAF Mutations in a Cohort of Patients With Colorectal Neoplasms Submitted for Microsatellite Instability Testing

Cushman-Vokoun, Allison M., Stover, Daniel G., Zhao, Zhiguo, Koehler, Elizabeth A., Berlin, Jordan D., Vnencak-Jones, Cindy L.

Journal:

Clinical Colorectal Cancer

Year:

2013

Language:

english

File:

PDF, 573 KB

english, 2013

4

Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer

Shankaran, Veena, Mummy, David, Koepl, Lisel, Blough, David, Yim, Yeun Mi, Yu, Elaine, Ramsey, Scott

Journal:

Clinical Colorectal Cancer

Year:

2013

Language:

english

File:

PDF, 150 KB

english, 2013

5

Editorial Board

Journal:

Clinical Colorectal Cancer

Year:

2013

Language:

english

File:

PDF, 101 KB

english, 2013

6

Adenovirus-Mediated Transcriptional Targeting of Colorectal Cancer and Effects on Treatment-Resistant Hypoxic Cells

Rajendran, Simon, O'Sullivan, Gerald C., O'Hanlon, Deirdre, Tangney, Mark

Journal:

Clinical Colorectal Cancer

Year:

2013

Language:

english

File:

PDF, 482 KB

english, 2013

7

Comparison of KRAS Genotype: Therascreen Assay vs. LNA-Mediated qPCR Clamping Assay

Chang, Shao-Chun, Denne, Jonathan, Zhao, Luping, Horak, Christine, Green, George, Khambata-Ford, Shirin, Bray, Christopher, Celik, Ilhan, Van Cutsem, Eric, Harbison, Christopher

Journal:

Clinical Colorectal Cancer

Year:

2013

Language:

english

File:

PDF, 319 KB

english, 2013

8

Discordance of KRAS Mutational Status in a Single Colonic Resection Specimen in a Patient With Colorectal Cancer: A Case Report and Review of the Literature

Smaglo, Brandon G., Marshall, John L.

Journal:

Clinical Colorectal Cancer

Year:

2013

Language:

english

File:

PDF, 132 KB

english, 2013

9

FOLFIRI-Bevacizumab As First-Line Chemotherapy in 3500 Patients With Advanced Colorectal Cancer: A Pooled Analysis of 29 Published Trials

Petrelli, Fausto, Borgonovo, Karen, Cabiddu, Mary, Ghilardi, Mara, Lonati, Veronica, Maspero, Federica, Sauta, Maria Grazia, Beretta, Giordano Domenico, Barni, Sandro

Journal:

Clinical Colorectal Cancer

Year:

2013

Language:

english

File:

PDF, 904 KB

english, 2013

10

Incidence of Chemotherapy-Induced Amenorrhea in Premenopausal Women Treated With Adjuvant FOLFOX for Colorectal Cancer

Cercek, Andrea, Siegel, Cara L., Capanu, Marinela, Reidy-Lagunes, Diane, Saltz, Leonard B.

Journal:

Clinical Colorectal Cancer

Year:

2013

Language:

english

File:

PDF, 963 KB

english, 2013

11

The Predictive and Prognostic Value of Sex in Early-Stage Colon Cancer: A Pooled Analysis of 33,345 Patients from the ACCENT Database

Cheung, Winson Y., Shi, Qian, O'Connell, Michael, Cassidy, James, Blanke, Charles D., Kerr, David J., Meyers, Jeff, Van Cutsem, Eric, Alberts, Steven R., Yothers, Greg, Sargent, Daniel J.

Journal:

Clinical Colorectal Cancer

Year:

2013

Language:

english

File:

PDF, 664 KB

english, 2013

Volume 12; Issue 3

Adjuvant Systemic Chemotherapy After Putative Curative Resection of Colorectal Liver and Lung Metastases

Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer

Clinical Utility of KRAS and BRAF Mutations in a Cohort of Patients With Colorectal Neoplasms Submitted for Microsatellite Instability Testing

Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer

Editorial Board

Adenovirus-Mediated Transcriptional Targeting of Colorectal Cancer and Effects on Treatment-Resistant Hypoxic Cells

Comparison of KRAS Genotype: Therascreen Assay vs. LNA-Mediated qPCR Clamping Assay

Discordance of KRAS Mutational Status in a Single Colonic Resection Specimen in a Patient With Colorectal Cancer: A Case Report and Review of the Literature

FOLFIRI-Bevacizumab As First-Line Chemotherapy in 3500 Patients With Advanced Colorectal Cancer: A Pooled Analysis of 29 Published Trials

Incidence of Chemotherapy-Induced Amenorrhea in Premenopausal Women Treated With Adjuvant FOLFOX for Colorectal Cancer

Table of Contents

The Predictive and Prognostic Value of Sex in Early-Stage Colon Cancer: A Pooled Analysis of 33,345 Patients from the ACCENT Database